Kawata A - Search Results

1

[Adopted immunochemotherapy using IL-2 and spleen LAK cell--randomized study].

Une Y, Kawata A, Uchino J. Une Y, et al. Among authors: kawata a. Nihon Geka Gakkai Zasshi. 1991 Sep;92(9):1330-3. Nihon Geka Gakkai Zasshi. 1991. PMID: 1658591 Clinical Trial. Japanese.

2

Modification of lymphokine-activated killer cell accumulation into tumor sites by chemotherapy, local irradiation, or splenectomy.

Kawata A, Hosokawa M, Sawamura Y, Ito K, Une Y, Shibata T, Uchino J, Kobayashi H. Kawata A, et al. Mol Biother. 1990 Dec;2(4):221-7. Mol Biother. 1990. PMID: 2288722

3

Adjuvant chemoimmunotherapy for hepatocellular carcinoma patients. Adriamycin, interleukin-2, and lymphokine-activated killer cells versus adriamycin alone.

Kawata A, Une Y, Hosokawa M, Wakizaka Y, Namieno T, Uchino J, Kobayashi H. Kawata A, et al. Am J Clin Oncol. 1995 Jun;18(3):257-62. doi: 10.1097/00000421-199506000-00014. Am J Clin Oncol. 1995. PMID: 7747715 Clinical Trial.

4

Postoperative chemoimmunotherapy for the treatment of liver cancer.

Uchino J, Une Y, Kawata A, Wakisaka Y, Hosokawa M. Uchino J, et al. Among authors: kawata a. Semin Surg Oncol. 1993 Jul-Aug;9(4):332-6. doi: 10.1002/ssu.2980090410. Semin Surg Oncol. 1993. PMID: 8210915 Clinical Trial.

5

Tumor-infiltrating lymphocytes and prognosis of hepatocellular carcinoma.

Kawata A, Une Y, Hosokawa M, Uchino J, Kobayashi H. Kawata A, et al. Jpn J Clin Oncol. 1992 Aug;22(4):256-63. Jpn J Clin Oncol. 1992. PMID: 1331571

6

Age-related, different clinicopathologic features of hepatocellular carcinoma patients.

Namieno T, Kawata A, Sato N, Kondo Y, Uchino J. Namieno T, et al. Among authors: kawata a. Ann Surg. 1995 Mar;221(3):308-14. doi: 10.1097/00000658-199503000-00014. Ann Surg. 1995. PMID: 7536406 Free PMC article.

7

[Progress in targeting therapy for hepatic cancer].

Uchino J, Une Y, Kamiya T, Kawata A. Uchino J, et al. Among authors: kawata a. Gan To Kagaku Ryoho. 1994 May;21(6):765-71. Gan To Kagaku Ryoho. 1994. PMID: 8185333 Review. Japanese.

8

Cystadenoma of the liver treated by hepatic resection.

Une Y, Kawata A, Kawamukai Y, Nakagawa T, Nojima T, Shimamura T, Uchino J. Une Y, et al. Among authors: kawata a. Oncol Rep. 1996 Jul;3(4):719-22. doi: 10.3892/or.3.4.719. Oncol Rep. 1996. PMID: 21594441

9

Surgical approach to tumor recurrence and metastatic lesions of the liver in a patient with malignant endocrine tumors of the pancreas: case report.

Inagaki M, Aoyagi T, Nomura A, Yokoo H, Akabane M, Kawata A, Nakano S, Chiba A, Fujii T, Sakurai H, Tsukada T, Takahashi M. Inagaki M, et al. Among authors: kawata a. J Hepatobiliary Pancreat Surg. 2003;10(4):325-8. doi: 10.1007/s00534-002-0861-0. J Hepatobiliary Pancreat Surg. 2003. PMID: 14598155

10

Establishment of new SCID and nude mouse models of human B leukemia/lymphoma and effective therapy of the tumors with immunotoxin and monoclonal antibody: marked difference between the SCID and nude mouse models in the antitumor efficacy of monoclonal antibody.

Kawata A, Yoshida M, Okazaki M, Yokota S, Barcos M, Seon BK. Kawata A, et al. Cancer Res. 1994 May 15;54(10):2688-94. Cancer Res. 1994. PMID: 8168098

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

239 results

Search Page

Filters